These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 23589163

  • 1. Postmenopausal women treated with combination parathyroid hormone (1-84) and ibandronate demonstrate different microstructural changes at the radius vs. tibia: the PTH and Ibandronate Combination Study (PICS).
    Schafer AL, Burghardt AJ, Sellmeyer DE, Palermo L, Shoback DM, Majumdar S, Black DM.
    Osteoporos Int; 2013 Oct; 24(10):2591-601. PubMed ID: 23589163
    [Abstract] [Full Text] [Related]

  • 2. Differing effects of PTH 1-34, PTH 1-84, and zoledronic acid on bone microarchitecture and estimated strength in postmenopausal women with osteoporosis: an 18-month open-labeled observational study using HR-pQCT.
    Hansen S, Hauge EM, Beck Jensen JE, Brixen K.
    J Bone Miner Res; 2013 Apr; 28(4):736-45. PubMed ID: 23044908
    [Abstract] [Full Text] [Related]

  • 3. Changes in trabecular and cortical bone microarchitecture at peripheral sites associated with 18 months of teriparatide therapy in postmenopausal women with osteoporosis.
    Macdonald HM, Nishiyama KK, Hanley DA, Boyd SK.
    Osteoporos Int; 2011 Jan; 22(1):357-62. PubMed ID: 20458576
    [Abstract] [Full Text] [Related]

  • 4. Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT.
    Kawalilak CE, Johnston JD, Olszynski WP, Kontulainen SA.
    Osteoporos Int; 2014 Aug; 25(8):2057-66. PubMed ID: 24781379
    [Abstract] [Full Text] [Related]

  • 5. Effect of oral monthly ibandronate on bone microarchitecture in women with osteopenia-a randomized placebo-controlled trial.
    Chapurlat RD, Laroche M, Thomas T, Rouanet S, Delmas PD, de Vernejoul MC.
    Osteoporos Int; 2013 Jan; 24(1):311-20. PubMed ID: 22402673
    [Abstract] [Full Text] [Related]

  • 6. Six months of parathyroid Hormone (1-84) administered concurrently versus sequentially with monthly ibandronate over two years: the PTH and ibandronate combination study (PICS) randomized trial.
    Schafer AL, Sellmeyer DE, Palermo L, Hietpas J, Eastell R, Shoback DM, Black DM.
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3522-9. PubMed ID: 22791766
    [Abstract] [Full Text] [Related]

  • 7. A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
    Burghardt AJ, Kazakia GJ, Sode M, de Papp AE, Link TM, Majumdar S.
    J Bone Miner Res; 2010 Dec; 25(12):2558-71. PubMed ID: 20564242
    [Abstract] [Full Text] [Related]

  • 8. Comparative effects of teriparatide and ibandronate on spine bone mineral density (BMD) and microarchitecture (TBS) in postmenopausal women with osteoporosis: a 2-year open-label study.
    Senn C, Günther B, Popp AW, Perrelet R, Hans D, Lippuner K.
    Osteoporos Int; 2014 Jul; 25(7):1945-51. PubMed ID: 24760244
    [Abstract] [Full Text] [Related]

  • 9. Deterioration of trabecular plate-rod and cortical microarchitecture and reduced bone stiffness at distal radius and tibia in postmenopausal women with vertebral fractures.
    Wang J, Stein EM, Zhou B, Nishiyama KK, Yu YE, Shane E, Guo XE.
    Bone; 2016 Jul; 88():39-46. PubMed ID: 27083398
    [Abstract] [Full Text] [Related]

  • 10. Effects of Two Years of Teriparatide, Denosumab, or Both on Bone Microarchitecture and Strength (DATA-HRpQCT study).
    Tsai JN, Uihlein AV, Burnett-Bowie SM, Neer RM, Derrico NP, Lee H, Bouxsein ML, Leder BZ.
    J Clin Endocrinol Metab; 2016 May; 101(5):2023-30. PubMed ID: 26964731
    [Abstract] [Full Text] [Related]

  • 11. Effects of strontium ranelate and alendronate on bone microstructure in women with osteoporosis. Results of a 2-year study.
    Rizzoli R, Chapurlat RD, Laroche JM, Krieg MA, Thomas T, Frieling I, Boutroy S, Laib A, Bock O, Felsenberg D.
    Osteoporos Int; 2012 Jan; 23(1):305-15. PubMed ID: 21909729
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effects of three oral bisphosphonate therapies on the peripheral skeleton in postmenopausal osteoporosis: the TRIO study.
    Paggiosi MA, Peel N, McCloskey E, Walsh JS, Eastell R.
    Osteoporos Int; 2014 Dec; 25(12):2729-41. PubMed ID: 25074351
    [Abstract] [Full Text] [Related]

  • 13. Accuracy of trabecular structure by HR-pQCT compared to gold standard μCT in the radius and tibia of patients with osteoporosis and long-term bisphosphonate therapy.
    Krause M, Museyko O, Breer S, Wulff B, Duckstein C, Vettorazzi E, Glueer C, Püschel K, Engelke K, Amling M.
    Osteoporos Int; 2014 May; 25(5):1595-606. PubMed ID: 24566588
    [Abstract] [Full Text] [Related]

  • 14. Randomized controlled trial of daily teriparatide, weekly high-dose teriparatide, or bisphosphonate in patients with postmenopausal osteoporosis: The TERABIT study.
    Chiba K, Okazaki N, Kurogi A, Watanabe T, Mori A, Suzuki N, Adachi K, Era M, Yokota K, Inoue T, Yabe Y, Furukawa K, Kondo C, Tsuda K, Ota S, Isobe Y, Miyazaki S, Morimoto S, Sato S, Nakashima S, Tashiro S, Yonekura A, Tomita M, Osaki M.
    Bone; 2022 Jul; 160():116416. PubMed ID: 35398293
    [Abstract] [Full Text] [Related]

  • 15. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures.
    Stein EM, Liu XS, Nickolas TL, Cohen A, Thomas V, McMahon DJ, Zhang C, Yin PT, Cosman F, Nieves J, Guo XE, Shane E.
    J Bone Miner Res; 2010 Dec; 25(12):2572-81. PubMed ID: 20564238
    [Abstract] [Full Text] [Related]

  • 16. Consequences of Hyperthyroidism and Its Treatment for Bone Microarchitecture Assessed by High-Resolution Peripheral Quantitative Computed Tomography.
    Nicolaisen P, Obling ML, Winther KH, Hansen S, Hermann AP, Hegedüs L, Bonnema SJ, Brix TH.
    Thyroid; 2021 Feb; 31(2):208-216. PubMed ID: 32703114
    [Abstract] [Full Text] [Related]

  • 17. Nasal salmon calcitonin blunts bone microstructure alterations in healthy postmenopausal women.
    Rizzoli R, Sigaud A, Azria M, Herrmann FR.
    Osteoporos Int; 2015 Jan; 26(1):383-93. PubMed ID: 25566730
    [Abstract] [Full Text] [Related]

  • 18. The association between prevalent vertebral fractures and bone quality of the distal radius and distal tibia as measured with HR-pQCT in postmenopausal women with a recent non-vertebral fracture at the Fracture Liaison Service.
    Vranken L, Wyers CE, van Rietbergen B, Driessen JHM, Geusens PPMM, Janzing HMJ, van der Velde RY, van den Bergh JPW.
    Osteoporos Int; 2019 Sep; 30(9):1789-1797. PubMed ID: 31312863
    [Abstract] [Full Text] [Related]

  • 19. Cortical thinning and progressive cortical porosity in female patients with systemic lupus erythematosus on long-term glucocorticoids: a 2-year case-control study.
    Zhu TY, Griffith JF, Qin L, Hung VW, Fong TN, Au SK, Tang XL, Kun EW, Kwok AW, Leung PC, Li EK, Tam LS.
    Osteoporos Int; 2015 Jun; 26(6):1759-71. PubMed ID: 25736166
    [Abstract] [Full Text] [Related]

  • 20. In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography.
    Boutroy S, Bouxsein ML, Munoz F, Delmas PD.
    J Clin Endocrinol Metab; 2005 Dec; 90(12):6508-15. PubMed ID: 16189253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.